Infection and replication of human cytomegalovirus in bone marrow stromal cells: Effects on the production of IL-6, MIP-1α, and TGF-β1

Bone Marrow Transplantation

Volumn 19, Issue 5, 1997, Pages 471-480

  Taichman, R S ^a   Nassiri, M R ^a,b   Reilly, M J ^a   Ptak, R G ^a   Emerson, S G ^c   Drach, J C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow stromal cells; Cytokine; HCMV; Hematopoiesis

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHYLCELLULOSE; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; ERYTHROCYTE; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NORMAL HUMAN; PRIORITY JOURNAL; STROMA CELL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031054394     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700685     Document Type: Article

References (69)

1. Gehrz RC. Human cytomegalovirus: biology and clinical perspectives. Adv Pediatr 1991; 38: 203-232.
2. Griffiths PD. Current management of cytomegalovirus disease. J Med Virol 1993; (Suppl. 1): 106-111.
3. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12 (Suppl. 7): S754-S766.
4. Roizman B, Whitley R, Lopez C (eds). The Human Herpesviruses. Raven Press: New York, 1993.
5. Nii S. Electron microscopic study on the development of herpesviruses. J Electron Microsc 1991; 41: 414-423.
6. Wingard JR, Piantadosi S, Burns WH et al. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev Infect Dis 1990; 12: S793-S804.
7. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12: S754-S766.
8. Kondo K, Kaneshim H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 1994; 91: 11879-11883.
9. Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 1990; 87: 1386-1390.
10. Mutter W, Reddehase MJ, Busch FW et al. Failure in generating hematopoietic stem cells is the primary cause of death from cytomegalovirus disease in immunocompromised host. J Exp Med 1988; 167: 1645-1658.
11. Maciejewski JP, Brueming EE, Doahue RE et al. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992; 80: 170-178.
12. Reiser H, Kuhn J, Doerr HW et al. Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol 1986; 67: 2595-2604.
13. Preiksaitis JK, Janowska-Wiexzorek A. Persistence of cytomegalovirus in human long-term bone marrow culture: relationship to hemopoiesis. J Med Virol 1991; 35: 76-84.
14. Busch FW, Mutter W, Koszinowski UH, Reddehase MJ. Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J Virol 1991; 65: 981-984.
15. Dexter TM, Coutinho LH, Spooncer E et al. Stromal cells in haemopoiesis. Molecular Control of Haemopoiesis. Ciba Foundation Symposium, 1990.
16. Kittler E, Quesenberry PJ, Long MW, Wicha MS (eds). Stromal cells and clinical implications. The Hematopoietic Microenvironment: Functional Basis of Blood Cell Development. John Hopkins University Press: Baltimore, 1993, pp 49-76.
17. Trentin JJ. Tavassoli M (eds). Hematopoietic microenvironments: historical perspectives, status, projections. Handbook of the Hemopoietic Microenvironment. Humana Press: Clifton, NJ, 1989, pp 1-59.
18. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179: 1677-1682.
19. Torok-Storb B, Simmons P, Khaira D et al. Cytomegalovirus and marrow function. Ann Hematol 1992; 64: A128-A131.
20. Apperley JF, Dowding C, Hibbin J et al. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol 1989; 17: 38-45.
21. Sing GK, Ruscetti FW. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 1990; 75: 1965-1973.
22. Steinberg HN, Anderson J Jr, Lim B, Chatis PA. Cytomegalovirus infection of the BS-1 human stromal cell line: effect on murine hemopoiesis. Virology 1993; 196: 427-432.
23. Kramvis A, Garnett HM. Infection of vervet monkey bone marrow stromal cells with simian cytomegalovirus. J Infect Dis 1987; 156: 645-648.
24. MacKintosh RF, Adlish J, Hall SW et al. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol 1993; 21: 243-250.
25. Torok-Storb B, Fries B, Stachel D, Kharira D. Cytomegalovirus:variations in tropism and disease. Leukemia 1993; 7: S83-S85 (Abstr.).
26. Duncombee AS, Meager A, Prentice HG et al. Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus. Blood 1990; 76: 1046-1053.
27. Lagneaux L, Delforge A, Snoeck R et al. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp Hematol 1994; 22: 26-30.
28. Almeida GD, Porada CD, St Jeor S, Ascensao JL. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994; 83: 370-376.
29. Dilloo D, Josting A. CMV infection modulates interleukin-6 production in human bone marrow stroma. Bone Marrow Transplant 1991; 7: (Suppl. 2): 152.
30. Plotkin SA, Farquhar J, Horberger E. Clinical trials of immunization with Towne 125 strain of human cytomegalovirus. J Infect Dis 1976; 134: 470-475.
31. Gibson W. Immediate-early proteins of human cytomegalovirus strains AD169, Davis, and Towne differ in electrophoretic mobility. Virology 1981; 112: 350-354.
32. Pritchett RF. DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus. J Virol 1980; 36: 152-161.
33. Sedarati F, Rosenthal LJ. Isolation and partial characterization of nucleocapsid forms from cells infected with human cytomegalovirus strains AD169 and Towne. Intervirology 1988; 29: 86-100.
34. Pande H, Campo K, Churchill MA, Zaia JA. Genomic locus for a 140 kDa structural protein (pp150) of human cytomegalovirus in strains Towne and AD169. Virus Res 1989; 12: 11-18.
35. Pande H, Lee TD, Churchill MA, Zaia JA. Structural analysis of a 64-kDa major structural protein of human cytomegalovirus (Towne): identification of a phosphorylation site and comparison to pp65 of HCMV (AD169). Virology 1990; 178: 6-14.
36. Honda J, Hoshino T, Natori H et al. Rapid and sensitive diagnosis of cytomegalovirus and Pneumocystis carinii pneumonia in patients with haematological neoplasia by using polymerase chain reaction. Br J Haematol 1994; 86: 138-142.
37. Steinberg MR, Thompsen DR, Stinki MF. Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol 1984; 49: 190-199.
38. Plotkin SA, Furukawa T, Zygraich N, Huygelen C. Candidate cytomegalovirus stain for human vaccination. Infect Immun 1975; 12: 521-527.
39. Prichard MN, Turk SL, Coleman LA et al. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex vurus. J Virol Meth 1990; 28: 101-106.
40. Irmiere A, Gibson W. Isolation and characterization of a non-infectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 1983; 130: 118-133.
41. Metcalf D. The Molecular Control of Blood Cells. Harvard University Press: Cambridge, MA, 1988.
42. Ruscetti RW, Jacobsen SE, Birchenall-Robers M et al. Role of transforming growth factor-beta 1 in regulation of hematopoiesis. Proc Natl Acad Sci USA 1991; 628: 31-43.
43. Keller JR, Bartelmez SH, Sitnicka E et al. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Blood 1994; 84: 2175-2181.
44. Mayani H, Little MT, Dragowska W et al. Differential effects for the hematopoietic inhibitors MIP-1 alpha. TGF-Beta and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Exp Hematol 1995; 23: 422-427.
45. Cocchi F, DeVico AL, Garzino-Demo A et al. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-1815.
46. Furukawa T. Cell cycle-dependent chronic infection of human cytomegalvirus in human osteosarcoma cells. J Gen Virol 1979; 45: 81-88.
47. Broxmeyer HE, Sherry B, Cooper S et al. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol 1991; 147: 2586-2594.
48. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63: 245-247.
49. Michelson S, Alcami J, Kim SJ et al. Human cytomegalovirus infection induces the transcription and secretion of transforming growth factor beta 1. J Virol 1994; 68: 5730-5737.
50. Muller MT,Hudson JB. Cell cycle dependency of murine cytomegalovirus replication in synchronized 3T3 cells. J Virol 1977; 22: 267-272.
51. Furukawa T. Cell cycle-dependent chronic infection of human cytomegalovirus in human osteogenic sarcoma cells. J Gen Virol 1979; 45: 81-88.
52. Waegell WO, Higley HR, Kincade PW, Dasch JR. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta. Exp Hematol 1994; 22: 1051-1057.
53. Alcami J, Paya CV, Virelizier JL, Michelson S. Antagonistic modulation of human cytomegalovirus replication by transforming growth factor beta and basic fibroblast growth factor. J Gen Virol 1993; 74: 269-274.
54. Paralkar VM, Vukicevic S, Reddi AH. Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Bio 1991; 143: 303-308.
55. Fukushima D, Butzow R, Hildebrand A, Ruoslahti E. Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. J Biol Chem 1993; 268: 22710-22715.
56. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-869.
57. Cook DN, Beck MA, Coffman TM et al. Requirements of MIP-1alpha for an inflammatory response to viral infections. Science 1995; 269: 1583-1586.
58. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 1993; 90: 12015-12019.
59. Fahey TJ III, Sherry B, Tracey KJ et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP2, cachectin/TNF and IL-1. Cytokine 1990; 2: 92-99.
60. Orolsky A, Berger MS, Prystowsky MB. Novel expression pattern of a new member of the MIP-1 family of cytokine genes. Cell Regul 1995; 2: 403-412.
61. Mancini GC, Durand B, Samal B et al. Effects of macrophage-inhibitory protein 1 (MIP-1 alpha) and leukemia-inhibitory factor (LIF) in long-term cultures of human CD34+ cord blood cells. Exp Hematol 1992; 20: 753 (Meeting Abstr.).
62. Lagneaux L, Delforge A, Snoeck R et al. Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 1996; 87: 59-66.
63. Bron D, Lagneaux L, Delfoge A et al. Prevention of CMV-induced myelosuppresion by anti-CMV antibodies: an in vitro model. Exp Hematol 1991; 19: 132-135.
64. Emanuel D, Childs B. Cytomegalovirus infection and compromise. Exp Hematol 1993; 21: 198-200.
65. Lagneaux L, Delforge A, Stryckmans P, Bron D. Cytomegalovirus-mediated myelosuppression. Exp Hematol 1993; 21: 837-838.
66. Haaomans BL, Stals FS, van der Mride PH et al. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol 1994; 68: 2297-2304.
67. Fietze E, Prosch S, Reinke P et al. Cytomegalovirus infection in transplant recipients. The role of tumour necrosis factor. Transplantation 1994; 58: 675-680.
68. Docke WD, Prosch S, Fietze E et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343: 268-269.
69. Shanley JD, Goff E, Debs RJ, Forman SJ. The role of tumor necrosis factor-alpha in acute murine cytomegalovirus infection in BALB/c mice. J Infect Dis 1994; 169: 1088-10891.